BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 28217782)

  • 1. Receptor for hyaluronan mediated motility (RHAMM/HMMR) is a novel target for promoting subcutaneous adipogenesis.
    Bahrami SB; Tolg C; Peart T; Symonette C; Veiseh M; Umoh JU; Holdsworth DW; McCarthy JB; Luyt LG; Bissell MJ; Yazdani A; Turley EA
    Integr Biol (Camb); 2017 Mar; 9(3):223-237. PubMed ID: 28217782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creating a Favorable Microenvironment for Fat Grafting in a Novel Model of Radiation-Induced Mammary Fat Pad Fibrosis.
    Truong JL; Liu M; Tolg C; Barr M; Dai C; Raissi TC; Wong E; DeLyzer T; Yazdani A; Turley EA
    Plast Reconstr Surg; 2020 Jan; 145(1):116-126. PubMed ID: 31881612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A RHAMM mimetic peptide blocks hyaluronan signaling and reduces inflammation and fibrogenesis in excisional skin wounds.
    Tolg C; Hamilton SR; Zalinska E; McCulloch L; Amin R; Akentieva N; Winnik F; Savani R; Bagli DJ; Luyt LG; Cowman MK; McCarthy JB; Turley EA
    Am J Pathol; 2012 Oct; 181(4):1250-70. PubMed ID: 22889846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of sequence, protein isoforms, and distribution of the hyaluronan-binding protein RHAMM in adult and developing rat brain.
    Lynn BD; Li X; Cattini PA; Turley EA; Nagy JI
    J Comp Neurol; 2001 Oct; 439(3):315-30. PubMed ID: 11596057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification, design and synthesis of tubulin-derived peptides as novel hyaluronan mimetic ligands for the receptor for hyaluronan-mediated motility (RHAMM/HMMR).
    Esguerra KV; Tolg C; Akentieva N; Price M; Cho CF; Lewis JD; McCarthy JB; Turley EA; Luyt LG
    Integr Biol (Camb); 2015 Dec; 7(12):1547-60. PubMed ID: 26456171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells.
    Hamilton SR; Fard SF; Paiwand FF; Tolg C; Veiseh M; Wang C; McCarthy JB; Bissell MJ; Koropatnick J; Turley EA
    J Biol Chem; 2007 Jun; 282(22):16667-80. PubMed ID: 17392272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of the hyaluronan receptor RHAMM prevents constrictive artery wall remodeling.
    Ma X; Pearce JD; Wilson DB; English WP; Edwards MS; Geary RL
    J Vasc Surg; 2014 Mar; 59(3):804-13. PubMed ID: 23768790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid, CD44 and RHAMM regulate myoblast behavior during embryogenesis.
    Leng Y; Abdullah A; Wendt MK; Calve S
    Matrix Biol; 2019 May; 78-79():236-254. PubMed ID: 30130585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Receptor for Hyaluronan-Mediated Motility (CD168) promotes inflammation and fibrosis after acute lung injury.
    Cui Z; Liao J; Cheong N; Longoria C; Cao G; DeLisser HM; Savani RC
    Matrix Biol; 2019 May; 78-79():255-271. PubMed ID: 30098420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.
    Niedworok C; Kretschmer I; Röck K; Vom Dorp F; Szarvas T; Heß J; Freudenberger T; Melchior-Becker A; Rübben H; Fischer JW
    PLoS One; 2013; 8(9):e75681. PubMed ID: 24069434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin.
    Matou-Nasri S; Gaffney J; Kumar S; Slevin M
    Int J Oncol; 2009 Oct; 35(4):761-73. PubMed ID: 19724912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells.
    Song JM; Im J; Nho RS; Han YH; Upadhyaya P; Kassie F
    Mol Carcinog; 2019 Mar; 58(3):321-333. PubMed ID: 30365189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function-Blocking RHAMM Peptides Attenuate Fibrosis and Promote Antifibrotic Adipokines in a Bleomycin-Induced Murine Model of Systemic Sclerosis.
    Wu KY; Kim S; Liu VM; Sabino A; Minkhorst K; Yazdani A; Turley EA
    J Invest Dermatol; 2021 Jun; 141(6):1482-1492.e4. PubMed ID: 33242499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronic Acid (HA) Receptors and the Motility of Schwann Cell(-Like) Phenotypes.
    Ouasti S; Faroni A; Kingham PJ; Ghibaudi M; Reid AJ; Tirelli N
    Cells; 2020 Jun; 9(6):. PubMed ID: 32560323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The receptor for hyaluronan-mediated motility (RHAMM) expression in neonatal bronchiolar epithelium correlates negatively with lung air content.
    Markasz L; Savani RC; Sedin G; Sindelar R
    Early Hum Dev; 2018 Dec; 127():58-68. PubMed ID: 30312861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients.
    Tarullo SE; He Y; Daughters C; Knutson TP; Henzler CM; Price MA; Shanley R; Witschen P; Tolg C; Kaspar RE; Hallstrom C; Gittsovich L; Sulciner ML; Zhang X; Forster CL; Lange CA; Shats O; Desler M; Cowan KH; Yee D; Schwertfeger KL; Turley EA; McCarthy JB; Nelson AC
    J Pathol; 2023 Jul; 260(3):289-303. PubMed ID: 37186300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44.
    Masellis-Smith A; Belch AR; Mant MJ; Turley EA; Pilarski LM
    Blood; 1996 Mar; 87(5):1891-9. PubMed ID: 8634437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 2 (TLR2), transforming growth factor-β, hyaluronan (HA), and receptor for HA-mediated motility (RHAMM) are required for surfactant protein A-stimulated macrophage chemotaxis.
    Foley JP; Lam D; Jiang H; Liao J; Cheong N; McDevitt TM; Zaman A; Wright JR; Savani RC
    J Biol Chem; 2012 Oct; 287(44):37406-19. PubMed ID: 22948158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
    Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
    Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RHAMM expression tunes the response of breast cancer cell lines to hyaluronan.
    Carvalho AM; Soares da Costa D; Reis RL; Pashkuleva I
    Acta Biomater; 2022 Jul; 146():187-196. PubMed ID: 35577044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.